Zitieren

1. Kang JM, Shin DW, Kwon MY, et al. Stomach cancer screening and preventive behaviors in relatives of gastric cancer patients. World J Gastroenterol 2011;17(30):35183525.doi:10.3748/wjg.v17.i30.3518.10.3748/wjg.v17.i30.3518316325021941419Search in Google Scholar

2. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700-13. doi:10.1158/1055-9965.EPI-13-1057.10.1158/1055-9965.EPI-13-1057401937324618998Search in Google Scholar

3. Lee YC, Chen TH, Chiu HM, et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut.2013;62(5):676-82.doi: 10.1136/gutjnl-2012-302240.10.1136/gutjnl-2012-302240361868722698649Search in Google Scholar

4. Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: Prevention, screening and early diagnosis World J Gastroenterol. 2014;20(38):13842–13862. doi:10.3748/wjg.v20.i38.13842.10.3748/wjg.v20.i38.13842419456725320521Search in Google Scholar

5. Jennifer MY, Sue J.G, Karen MK, Majid E. Effects of Helicobacter pylori infection and smoking on gastric cancer incidence in China: a population-level analysis of trends and projections Cancer Causes Control. 2009;20(10): 2021–2029.doi:10.1007/s10552-009-9397-9.10.1007/s10552-009-9397-9290485519642005Search in Google Scholar

6. Lee YY, Derakhshan MH. Environmental and lifestyle risk factors of gastric cancer. Arch Iran Med. 2013;16(6):358-65. doi: 013166/AIM.0010.Search in Google Scholar

7. Machado AM, Figueiredo C, Seruca R, Rasmussen LJ. Helicobacter pylori infection generates genetic instability in gastric cells. Biochim Biophys Acta. 2010;1806(1):58-65.doi: 10.1016/j.bbcan.2010.01.007.10.1016/j.bbcan.2010.01.00720122996Search in Google Scholar

8. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784-9.doi:10.1056/NEJMoa001999.10.1056/NEJMoa00199911556297Search in Google Scholar

9. Watari J, Chen N, Amenta SP, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 2014;20(18):5461–5473.doi:10.3748/wjg.v20.i18.5461.10.3748/wjg.v20.i18.5461401706124833876Search in Google Scholar

10. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554–3560.Search in Google Scholar

11. Correa P, Piazuelo MB, The gastric precancerous cascade. J Dig Dis 2012;13(1):2-9.doi: 10.1111/j.1751-2980.2011.00550.x.10.1111/j.1751-2980.2011.00550.x340460022188910Search in Google Scholar

12. Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004;7(2):61-77. doi10.1007/s10120-004-0277-4.10.1007/s10120-004-0277-415224192Search in Google Scholar

13. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009;472:467–477.doi:10.1007/978-1-60327-492-0_23.10.1007/978-1-60327-492-0_23Search in Google Scholar

14. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet, 1975;2:58-60.10.1016/S0140-6736(75)90498-5Search in Google Scholar

15. Jernal A, Bray F, Center MM, et al. Globan cancer statistics. CA Cancer J Clin 2011;61:69-90.doi:10.3322/caac.20107.10.3322/caac.2010721296855Search in Google Scholar

16. http://globocan.iarc.fr/Pages/Map.aspxSearch in Google Scholar

17. Bastos J1, Peleteiro B, Barros R, et al. Sociodemographic determinants of prevalence and incidence of Helicobacter pylori infection in Portuguese adults. Helicobacter. 2013;18(6):413-22.doi:10.1111/hel.12061.10.1111/hel.1206123725608Search in Google Scholar

18. Saniee P, Shahreza S, Siavoshi F. Negative effect of proton-pump inhibitors (PPIs) on helicobacter pylori growth, morphology, and urease test and recovery after PPI removal - an in vitro study. Helicobacter. 2015;28.doi:10.1111/hel.12246.10.1111/hel.1224626222264Search in Google Scholar

19. Peleteiro B, Bastos A, Ferro A, Lunet N. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage. Dig Dis Sci. 2014;59(8):1698-709.doi:10.1007/s10620-014-3063-0.10.1007/s10620-014-3063-024563236Search in Google Scholar

20. Ogata SK, Kawakami E, Patrício FR, Pedroso MZ, Santos AM. Evaluation of invasive and non-invasive methods for the diagnosis of Helicobacter pylori infection in symptomatic children and adolescents. Sao Paulo Med J. 2001;119(2):67-71.doi.org/10.1590/S1516-31802001000200006.10.1590/S1516-31802001000200006Search in Google Scholar

21. Hahn M, Fennerty MB, Corless CL, et al. Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection. Gastrointest Endosc. 2000;52(1):20-6. doi:http://dx.doi.org/10.1067/mge.2000.106686.Search in Google Scholar

22. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74–94. doi:10.1055/s-0031-1291491.10.1055/s-0031-1291491336750222198778Search in Google Scholar

23. Zullo A, Hassan C, Romiti A, et. al. Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol 2012;4(3):30-36.doi:10.4251/wjgo.v4.i3.30.10.4251/wjgo.v4.i3.30331292622468181Search in Google Scholar

24. Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J Gastroenterol Hepatol 2009;24:193–201.doi:10.1111/j.1440-1746.2008.05774.x.10.1111/j.1440-1746.2008.05774.x19215332Search in Google Scholar

25. Kyrlagkitsis I, Karamanolis DG. Premalignant lesions and conditions for gastric adenocarcinoma: diagnosis, management and surveillance guidelines. Hepatogastroenterology. 2003;50(50):592-600.doi:10.5754/hge121268.Search in Google Scholar

26. Lea IV, Aino MO, Pentti IS, Hilpi IKR. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection. World J Gastroenterol. 2010;16(1):83–88.doi:10.3748/wjg.v16.i1.83.Search in Google Scholar

27. Faller G1, Kirchner T. Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch. 2005;446(1):1-9. doi10.1007/s00428-004-1157-3.10.1007/s00428-004-1157-315583929Search in Google Scholar

28. Cassaro M, Rugge M, Gutierrez O, et al. Topographic patterns of intestinal metpalasia and gastric cancer. Am J Gastroenterol 2000;95(6):1431-8doi:10.1038/ajg.2015.169.10.1038/ajg.2015.169Search in Google Scholar

29. Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010;105(3):493-8.doi:10.1038/ajg.2009.728.10.1038/ajg.2009.728289540720203636Search in Google Scholar

30. Eriksson NK, Kärkkäinen PA, Färkkilä MA, Arkkila PE. Prevalence and distribution of gastric intestinal metaplasia and its subtypes. Dig Liver Dis 2008;40(5):35560.doi:10.1016/j.dld.2007.12.012.10.1016/j.dld.2007.12.01218291729Search in Google Scholar

31. Zhang C, Yamada N, Wu YL, et al. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol. 2005;14;11(6):791-6.doi:10.3748/wjg.v11.i6.791.10.3748/wjg.v11.i6.791425058515682469Search in Google Scholar

32. Pacifico L, Anania C, Osborn JF, Ferraro F, Chiesa C. Consequences of Helicobacter pylori infection in children. World J Gastroenterol. 2010;16(41):51815194.doi:10.3748/wjg.v16.i41.5181.10.3748/wjg.v16.i41.5181297508921049552Search in Google Scholar

33. Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713-39.doi:10.1128/CMR.0001110.Search in Google Scholar

eISSN:
2247-6113
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
6 Hefte pro Jahr
Fachgebiete der Zeitschrift:
Medizin, Klinische Medizin, andere